Literature DB >> 17613527

Unique N-region determines low basal activity and limited inducibility of A-RAF kinase: the role of N-region in the evolutionary divergence of RAF kinase function in vertebrates.

Angela Baljuls1, Thomas Mueller, Hannes C A Drexler, Mirko Hekman, Ulf R Rapp.   

Abstract

In mammals the RAF family of serine/threonine kinases consists of three members, A-, B-, and C-RAF. A prominent feature of RAF isoforms regards differences in basal and inducible kinase activities. To elucidate the nature of these differences, we studied the role of the nonconserved residues within the N-region (Negative-charge regulatory region). The nonconserved amino acids in positions -3 and +1 relative to the highly conserved serine 299 in A-RAF and serine 338 in C-RAF have so far not been considered as regulatory residues. Here we demonstrate the essential role of these residues in the RAF activation process. Substitution of tyrosine 296 in A-RAF to arginine led to a constitutively active kinase. In contrast, substitution of glycine 300 by serine (mimicking B- and C-RAF) acts in an inhibitory manner. Consistent with these data, the introduction of glycine in the analogous position of C-RAF (S339G mutant) led to a constitutively active C-RAF kinase. Based on the three-dimensional structure of the catalytic domain of B-RAF and using the sequences of the N-regions of A- and C-RAF, we searched by molecular modeling for the putative contact points between these two moieties. A tight interaction between the N-region residue serine 339 of C-RAF and arginine 398 of the catalytic domain was identified and proposed to inhibit the kinase activity of RAF proteins, because abrogation of this interaction contributes to RAF activation. Furthermore, tyrosine 296 in A-RAF favors a spatial orientation of the N-region segment, which enables a tighter contact to the catalytic domain, whereas a glutamine residue at this position in C-RAF abrogates this interaction. Considering this observation, we suggest that tyrosine 296, which is unique for A-RAF, is a major determinant of the low activating potency of this RAF isoform.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17613527     DOI: 10.1074/jbc.M702429200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  c-Myc regulates RNA splicing of the A-Raf kinase and its activation of the ERK pathway.

Authors:  Jens Rauch; Kim Moran-Jones; Valerie Albrecht; Thomas Schwarzl; Keith Hunter; Olivier Gires; Walter Kolch
Journal:  Cancer Res       Date:  2011-04-21       Impact factor: 12.701

2.  Different Raf protein kinases mediate different signaling pathways to stimulate E3 ligase RFFL gene expression in cell migration regulation.

Authors:  Xiaoqing Gan; Chen Wang; Maulik Patel; Barry Kreutz; Maggie Zhou; Tohru Kozasa; Dianqing Wu
Journal:  J Biol Chem       Date:  2013-10-10       Impact factor: 5.157

3.  Tyr728 in the kinase domain of the murine kinase suppressor of RAS 1 regulates binding and activation of the mitogen-activated protein kinase kinase.

Authors:  Claudia Sibilski; Thomas Mueller; Laxmikanth Kollipara; René P Zahedi; Ulf R Rapp; Thomas Rudel; Angela Baljuls
Journal:  J Biol Chem       Date:  2013-10-24       Impact factor: 5.157

4.  Single substitution within the RKTR motif impairs kinase activity but promotes dimerization of RAF kinase.

Authors:  Angela Baljuls; Regina Mahr; Inge Schwarzenau; Thomas Müller; Lisa Polzien; Mirko Hekman; Ulf R Rapp
Journal:  J Biol Chem       Date:  2011-03-18       Impact factor: 5.157

5.  Spatial regulation of ARAF controls the MST2-Hippo pathway.

Authors:  Jens Rauch; Walter Kolch
Journal:  Small GTPases       Date:  2017-03-10

6.  Differential localization of A-Raf regulates MST2-mediated apoptosis during epithelial differentiation.

Authors:  J Rauch; D Vandamme; B Mack; B McCann; N Volinsky; A Blanco; O Gires; W Kolch
Journal:  Cell Death Differ       Date:  2016-02-19       Impact factor: 15.828

7.  Raf family kinases: old dogs have learned new tricks.

Authors:  David Matallanas; Marc Birtwistle; David Romano; Armin Zebisch; Jens Rauch; Alexander von Kriegsheim; Walter Kolch
Journal:  Genes Cancer       Date:  2011-03

8.  ARAF protein kinase activates RAS by antagonizing its binding to RASGAP NF1.

Authors:  Wenjing Su; Radha Mukherjee; Rona Yaeger; Jieun Son; Jianing Xu; Na Na; Neilawattie Merna Timaul; Jaclyn Hechtman; Viktoriya Paroder; Mika Lin; Marissa Mattar; Juan Qiu; Qing Chang; Huiyong Zhao; Jonathan Zhang; Megan Little; Yuta Adachi; Sae-Won Han; Barry S Taylor; Hiromichi Ebi; Omar Abdel-Wahab; Elisa de Stanchina; Charles M Rudin; Pasi A Jänne; Frank McCormick; Zhan Yao; Neal Rosen
Journal:  Mol Cell       Date:  2022-05-24       Impact factor: 19.328

9.  Allosteric activation of functionally asymmetric RAF kinase dimers.

Authors:  Jiancheng Hu; Edward C Stites; Haiyang Yu; Elizabeth A Germino; Hiruy S Meharena; Philip J S Stork; Alexandr P Kornev; Susan S Taylor; Andrey S Shaw
Journal:  Cell       Date:  2013-08-29       Impact factor: 41.582

10.  A-RAF kinase functions in ARF6 regulated endocytic membrane traffic.

Authors:  Elena Nekhoroshkova; Stefan Albert; Matthias Becker; Ulf R Rapp
Journal:  PLoS One       Date:  2009-02-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.